For instance, DLC-1 expression is reduced 10-fold in lung adenocarcinoma, 3-fold in hepatocellular carcinoma, 4-fold in breast cancer, and 3-fold in colon cancer [12]. Here, DLC1 is linked to colonic neoplasm.